IL1B and COVID-19: Considering our sample size and IL-1β’s role in the initiation of cytokine release syndrome and induced secretion of IL-6 [38], it may be advisable to consider the ratio of these cytokines (i.e. IL-1β/IL-6) to better understand the cytokine profile in COVID-19 patients and the associated inflammatory state.